Skip to main content
. 2007 Jan-Feb;14(1):48–55. doi: 10.1197/jamia.M2248

Table 2.

Table 2. Leapfrog CPOE Evaluation Test Clinical Decision Support Categories

Therapeutic Duplication Therapeutic overlap with another new or active order; may be same drug, same drug class, or components of combination products.
Single and Cumulative Dose Limits Specified dose that exceeds recommended dose ranges; will result in a cumulative dose that exceeds recommended ranges; can also include does limits for each component of a combination product.
Allergies and Cross Allergies Allergy has been documented or allergy to other drug in same category exists.
Contraindicated Route of Administration Order specifying a route of administration that is not appropriate for the identified medication.
Drug–Drug and Drug–Food Interactions Results in known, dangerous interaction when administered together with a different medication or results in an interaction in combination with a drug or food group.
Contraindications/Dose Limits Based on Patient Diagnosis Contraindication based on patient diagnosis or diagnosis affects recommended dosing.
Contraindications/Dose Limits Based on Patient Age or Weight Contraindication based on age or weight.
Contraindications/Dose Limits Based on Laboratory Studies Contraindication based on laboratory studies or for which laboratory studies must be considered for dosing.
Contraindications/Dose Limits Based on Radiology Studies Contraindication for this patient based on interaction with contrast medium (in ordered radiology study).
Corollary Intervention that requires an associated or secondary order to meet the standard of care (prompt to order drug levels during medication ordering).
Cost of Care Test that duplicates a service within a timeframe in which there is typically minimal benefits from repeating the test.
Nuisance Order with such a slight or inconsequential interaction that clinicians typically ignore the advice/prompt.